Dr. Sanjay Rajput DM, MD , MBBS
Aartham Hospital, Ahmedabad
15 Years Experience
Professional Summary
Dr. Sanjay Rajput is a senior Consultant Gastroenterologist at Aartham Hospital in Ahmedabad, Gujarat, with over 15 years of expertise in diagnosing and treating disorders of the digestive system. He specializes in advanced endoscopic procedures, hepatology, and complex motility disorders, delivering patient-centered care that combines the latest technology with compassionate clinical judgment.
Hospital Affiliation
Aartham Hospital, Ahmedabad
Hospital Features: multi-specialty tertiary care, advanced endoscopy suite, liver transplant workup, comprehensive digestive health services, integrated wellness programs.
Specialization Areas
Clinical Gastroenterology
- Peptic ulcer disease and H. pylori management
- Gastroesophageal reflux disease (GERD) and Barrett's esophagus
- Irritable bowel syndrome (IBS) and functional bowel disorders
Hepatology
- Chronic liver disease management (NAFLD/NASH, viral hepatitis)
- Cirrhosis evaluation and portal hypertension care
- Pre- and post-liver transplant assessment
Advanced Endoscopy
- Diagnostic and therapeutic upper GI endoscopy
- Colonoscopy with polypectomy and EMR
- Endoscopic retrograde cholangiopancreatography (ERCP)
Motility & Pancreatobiliary Disorders
- Achalasia and esophageal motility studies
- Pancreatitis management and cyst drainage
- Biliary stone extraction and stenting
Treatment Philosophy
Dr. Rajput emphasizes a holistic, evidence-based approach:
- Thorough clinical evaluation and personalized care plans
- Minimally invasive techniques to reduce discomfort and recovery time
- Integration with nutritionists, physiotherapists, and support teams
- Ongoing patient education and preventive health strategies
Advanced Procedures
1. Diagnostic & Therapeutic Upper GI Endoscopy
– Variceal banding, foreign body removal, dilation
2. Colonoscopy & Polypectomy
– Screening colonoscopy, EMR for early lesions
3. Endoscopic Retrograde Cholangiopancreatography (ERCP)
– Stone removal, stricture management, stent placement
4. Endoscopic Ultrasound (EUS)
– Pancreatic cyst evaluation, FNA for tissue diagnosis
5. Motility Studies
– Manometry for esophageal and anorectal disorders
Support Services
- Nutritional counseling for liver and GI disorders
- Bowel preparation education and compliance support
- Post-procedure recovery and complication monitoring
- Patient wellness plans through Aartham Hospital's Gold, Platinum, Diamond packages
Reopine Consultation Details
Available Services:
- First Opinion Consultations – Initial GI evaluation
- Second Opinion Reviews – Diagnostic report interpretation
- Endoscopy Planning – Pre- and post-procedure guidance
- Chronic Liver Disease Consultations – Long-term management
- Motility Disorder Management – Customized treatment plans
Languages Spoken:
- English (Fluent)
- Hindi (Fluent)
- Gujarati (Fluent)
Book Your Consultation
Dr. Sanjay Rajput offers expert gastroenterology consultations through Reopine's virtual platform, ensuring secure, professional guidance for all digestive health concerns.
Date: 05 Nov 2025
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 05 Nov 2025
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.